(Q74216091)
Statements
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (English)
Fraker DL
Alexander HR
Bartlett DL
Puhlmann M
scientific article published on 01 August 2000